Akums Drugs and Pharmaceuticals’ shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subscribed 63.5 times. The company will use the IPO proceeds for debt repayment, working capital, and acquisitions. Revenue grew 14% in FY24, while profits saw a decline.
‘On the edge…’: What social media conversations reveal about the current market mood
Social media analysis reveals bleak market sentiments among investors and experts. Market veteran Shankar Sharma highlights that the downturn is local and needs local solutions.